Podcast
Monty Pal
Pushing the Limits of Cancer Research and Surgery
Clips
Summary
Dr. Mustafa Raoof on PIPAC, pancreatic cancer research, and how global innovation can shape the next chapter of surgical oncology.
In this episode of On the Edge of Breakthrough: Voices of Cancer Research, Dr. Monty Pal talks with Mustafa Raoof, a leading surgical oncologist and physician-scientist at City of Hope, about the challenges and potential in treating some of the toughest cancers.
Dr. Raoof reflects on his path - from boarding school in Pakistan to pioneering new techniques in peritoneal metastasis treatment at a world renowned cancer center, including the promising intraperitoneal therapy known as Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC). He breaks down his lab's latest work on DNA repair in pancreatic cancer, shares his perspectives on the value of making research more accessible across low-resource settings, and discusses how he balances life as a researcher, surgeon, and his most important role as a dad.
This is a grounded, thoughtful conversation that spotlights how innovation meets real-world limitations, and why collaboration —not just within institutions, but across borders — is more essential than ever.
Related Topics
You May Also Like
Monty Pal
Podcast
Monty Pal
Reengineering CAR T for Solid Tumors: What Glioblastoma Has Taught Us with Christine Brown, Ph.D.
Article
Haiqing Isaac Dai, Yulia Vugmeyster, Naveen Mangal
Characterizing Exposure–Response Relationship for Therapeutic Monoclonal Antibodies in Immuno-Oncology and Beyond: Challenges, Perspectives, and Prospects
Article
Doreen A. Ezeife MD, Francois Dionne PhD, Aline Fusco Fares MD, Ellen Laura Rose Cusano MD, Rouhi Fazelzad BSc, MISt, Wenzie Ng BSc, MPharm, RPh, Don Husereau BSc Pharm, MSc, Farzad Ali BPharm, MSc, Christina Sit MSc, Barry Stein B.Com BCL, LLB, Jennifer
Value assessment of oncology drugs using a weighted criterion-based approach
Article
Kelvin Chan, Seungree Nam, Bill Evans, Claire de Oliveira Alexandra Chambers, Scott Gavura, Jeffrey Hoch, Rebecca E Mercer, Wei Fang Dai, Jaclyn Beca, Mina Tadrous, Wanrudee Isaranuwatchai
Developing a framework to incorporate real-world evidence in cancer drug funding decisions: the Canadian Real-world Evidence for Value of Cancer Drugs (CanREValue) collaboration
Article
Jakub P. Hlávka, PhD, Pei-Jung Lin, PhD, Peter J. Neumann, ScD